Insider Transactions in Q4 2020 at Incyte Corp (INCY)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
213
+1.43%
|
$18,318
$86.98 P/Share
|
|
Dec 31
2020
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
275
+2.99%
|
$23,650
$86.98 P/Share
|
|
Dec 31
2020
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+4.31%
|
$20,382
$86.98 P/Share
|
|
Dec 31
2020
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
281
+5.53%
|
$24,166
$86.98 P/Share
|
|
Dec 31
2020
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
207
+7.67%
|
$17,802
$86.98 P/Share
|
|
Dec 31
2020
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
686
+0.01%
|
-
|
|
Dec 11
2020
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
128
+0.43%
|
$8,320
$65.36 P/Share
|
|
Dec 10
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
720
-2.46%
|
$59,040
$82.05 P/Share
|
|
Nov 16
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+4.04%
|
-
|
|
Nov 16
2020
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+2.9%
|
-
|
|
Nov 16
2020
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,225
+2.59%
|
-
|
|
Nov 16
2020
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+4.34%
|
-
|
|
Nov 16
2020
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+3.97%
|
-
|
|
Nov 16
2020
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+5.24%
|
-
|
|
Nov 16
2020
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+1.26%
|
-
|
|
Nov 16
2020
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+2.23%
|
-
|
|
Nov 16
2020
|
Yao Wenqing EVP, Head of Discovery Chem |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+0.78%
|
-
|
|
Nov 12
2020
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
127
+0.44%
|
$8,255
$65.36 P/Share
|
|
Nov 10
2020
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
798
-8.45%
|
$66,234
$83.0 P/Share
|
|
Nov 06
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
961
-3.32%
|
$81,685
$85.17 P/Share
|
|
Nov 06
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
961
+3.21%
|
$62,465
$65.42 P/Share
|
|
Nov 02
2020
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
20,000
-33.34%
|
$1,720,000
$86.6 P/Share
|
|
Nov 02
2020
|
Barry P Flannelly EVP & General Manager US |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+25.01%
|
$960,000
$48.44 P/Share
|
|
Oct 12
2020
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
128
+0.45%
|
$8,320
$65.36 P/Share
|
|
Oct 09
2020
|
Maria E Pasquale EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
1,423
-4.78%
|
$135,185
$95.0 P/Share
|
|
Oct 09
2020
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,423
+4.56%
|
$96,764
$68.62 P/Share
|
|
Oct 06
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
961
-3.32%
|
$87,451
$91.97 P/Share
|
|
Oct 06
2020
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
961
+3.21%
|
$62,465
$65.42 P/Share
|